Note: You are experiencing problems viewing our site due to compatability issues with your browser. Although you are not seeing the intended design, you should still have access to the site content. For full viewing capability, our System Requirements page will provide you with information and links to several browser options.

Morgan Keegan logo

•   home » our story » news & events » press releases » morgan keegan hires keusch, continues growth in healthcare industry 05/14/09   •

Morgan Keegan Hires Keusch, Continues Growth in Healthcare Industry

MEMPHIS, Tenn. (May 14, 2009) — Morgan Keegan & Company, Inc. has announced that Lawrence Keusch has joined the firm as a senior equity analyst and managing director. Keusch, a 23-year veteran of the equity research industry, will cover the medical technology sector for the Equity Capital Markets Group and will be based in the firm’s Boston office.

Keusch’s addition further extends Morgan Keegan’s expansion in the healthcare industry. In 2007, the firm acquired Shattuck Hammond Partners, an investment banking and financial advisory group that specializes in the healthcare industry. Also in 2007, healthcare services industry research analyst Robert Mains joined the firm.

"The healthcare industry represents one-sixth of the U.S. economy and provides numerous opportunities for today’s investors. We are very pleased to expand our research coverage in that industry for our clients," said Elkan Scheidt, Director of Equity Research for Morgan Keegan. "Lawrence is one of the most experienced and knowledgeable analysts in the medical technology sector and we are pleased that he has joined our research team."

Prior to joining Morgan Keegan, Keusch spent 21 years at Goldman Sachs & Co as a managing director in the firm’s Global Investment Research department. While at Goldman Sachs, he served as co-head of the U.S. Healthcare team and was on the Investment Review Committee. He has covered medical device companies since 1992, and has been recognized in both Institutional Investor and Greenwich investor polls. Most recently, he was runner-up in the 2008 Institutional Investor All-America Research poll. He graduated from Tufts University in 1986 with a B.S. in Biology.

Morgan Keegan’s Equity Capital Markets Group encompasses sales, trading, research and investment banking operations. The group has over 300 employees including sales people, traders, analysts and investment bankers working from institutional offices in Memphis, New York, Boston, Atlanta, Nashville and Houston.

About Morgan Keegan
Morgan Keegan & Company, Inc., one of the largest full-service brokerage and investment banking firms in the nation, is the securities brokerage arm of Regions Financial Corp. (NYSE: RF). Headquartered in Memphis, Tenn., Morgan Keegan has some 300 offices in 19 states and more than 4,300 employees. Additional information about Morgan Keegan can be found at www.morgankeegan.com.

About Regions Financial Corporation
Regions Financial Corporation, with $142 billion in assets, is a member of the S&P 100 Index and one of the nation’s largest full-service providers of consumer and commercial banking, trust, securities brokerage, mortgage and insurance products and services. Regions serves customers in 16 states across the South, Midwest and Texas, and through its subsidiary, Regions Bank, operates 1,900 banking offices and approximately 2,300 ATMs. Additional information about Regions and its full line of products and services can be found at www.regions.com.